ChemT Biotechnology

Virtual Cell for Biomanufacturing

Singapore, Singapore · Founded 2024 · $4.0M raised

Headquarters
Singapore
Employees
1–10
Founded
2024
Business Model
B2B
Total Funding
$4.0M
Last Round
$4.0M SeedJun 2026
Rounds
2

About

ChemT Biotechnology is an AI-driven biotech company based in Singapore and the United States, founded in October 2024 by CEO Jie Sun and President Dr. Ling Wu. The company is building the AI intelligence layer for CMC (Chemistry, Manufacturing & Controls) in pharma, with its proprietary CelMo virtual cell platform at the core — using AI-designed small molecules to modulate cells for improved growth, productivity, and product quality in biologics production. ChemT's technology targets faster process development, smoother validation, and lower-cost biologics manufacturing, with applications in cell therapy. The company is a member of Eli Lilly's TuneLab AI/ML innovation platform.

Summary

ChemT Biotechnology is an Artificial Intelligence company based in Singapore, Singapore, founded in 2024. It has raised $4.0M in total across 2 rounds, most recently a $4.0M Seed round in Jun 2026. Investors include Wavemaker Partners and Draper University.

Funding History

SeedJun 2026
$4.0M

Sign up to see all 2 rounds

Angel through Seed — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ChemT Biotechnology on Indexed.vc
<a href="https://indexed.vc/companies/chemt-biotechnology"><img src="https://indexed.vc/api/badge/company/chemt-biotechnology" alt="ChemT Biotechnology on Indexed.vc" width="260" height="76" /></a>